Top Markets
Coin of the day
SymBio Pharmaceuticals Limited SymBio Pharmaceuticals Limited

SymBio Pharmaceuticals Limited

4582
Rank in Stocks #28752
SymBio Pharmaceuticals Limited engages in the and development, manufacturing... SymBio Pharmaceuticals Limited engages in the and development, manufacturing and sales of pharmaceuticals and other related operations in Japan and internationally. It offers SyB V-1901, an antiviral drug for post-transplant infections, blood cancers and solid tumors, and neurodegenerative diseases; SyB L-1701, an RTD liquid formulation; and SyB L-1702, an RI administration under the TREAKISYM name. The company was incorporated in 2005 and is based in Minato, Japan.
Share Price
$0.45018154
Market Cap
$24.81M
Change (1 day)
1.47%
Change (1 year)
-56.57%
Country
JP
Trade SymBio Pharmaceuticals Limited (4582)

Category

Earnings for SymBio Pharmaceuticals Limited (4582)
Earnings in 2026 TTM: 0
According to SymBio Pharmaceuticals Limited latest financial reports the company's current earnings are 0. In 2026 the company made an earning of 0, equal to its 2026 earnings that were of 0. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for SymBio Pharmaceuticals Limited from 2026 to 2026
Earnings at the end of each year
Year Earnings Change
Not enough data for the provided dates.
Earnings for similar companies or competitors